Therefore, it could be deduced that luteoloside inhibits the proliferation and metastasis of HCC cells by inhibiting NLRP3 inflammasome through reducing intracellular ROS (Fan et al., 2014). The gene discussed is NLRP3; the disease is hepatocellular carcinoma.